Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 135

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 135
---
a-15(f) and 15d-15(f) under the
Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief
Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting. Management has used
the framework set forth in the report entitled “Internal Control-Integrated Framework (2013)” published by the Committee of
Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of our internal control over financial reporting. Based
on that assessment, our management has identified certain material weaknesses in our internal control over financial reporting.

Our management concluded that as of March 31, 2025,
our internal control over financial reporting was not effective, and that material weaknesses existed in the following areas:

(1)we do not employ full time
in-house personnel with the technical knowledge to identify and address some of the reporting issues surrounding certain complex or non-routine
transactions. With respect to material, complex and non-routine transactions, management has and will continue to seek guidance from
third-party experts and/or consultants to gain a thorough understanding of these transactions;

(2)we have inadequate segregation
of duties consistent with the control objectives including but not limited to the disbursement process, transaction or account changes,
and the performance of account reconciliations and approval; and

(3)we have ineffective controls
over the period end financial disclosure and reporting process caused by insufficient accounting staff.

Limitations on Effectiveness of Controls and
Procedures

In
designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes
that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired
control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must
reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of
possible controls and procedures relative to their costs. 

Changes in Internal Control over Financial
Reporting

There were no changes in our internal control
over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.

35

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEDINGS

From time to time, claims are made against us
in the ordinary course of business, which could result in litigation. Claims and associated litigation